Click for best price
Brucellosis Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 11 million
|
Forecast Market size by 2029 |
US$ 14 million
|
| Growth Rate |
CAGR of 3.5% |
Number of Pages |
116 Pages |
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
This report aims to provide a comprehensive presentation of the global market for Brucellosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucellosis Vaccines. This report contains market size and forecasts of Brucellosis Vaccines in global, including the following market information:
Global Brucellosis Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Brucellosis Vaccines Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Brucellosis Vaccines companies in 2022 (%)
The global Brucellosis Vaccines market was valued at US$ 11 million in 2022 and is projected to reach US$ 14 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
We surveyed the Brucellosis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brucellosis Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Brucellosis Vaccines Market Segment Percentages, by Type, 2022 (%)
S19 Vaccine
RB51 Vaccine Strain
Global Brucellosis Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Brucellosis Vaccines Market Segment Percentages, by Application, 2022 (%)
Cattle
Sheep
Others
Global Brucellosis Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Brucellosis Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brucellosis Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Brucellosis Vaccines revenues share in global market, 2022 (%)
Key companies Brucellosis Vaccines sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Brucellosis Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brucellosis Vaccines, market overview.
Chapter 2: Global Brucellosis Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brucellosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Brucellosis Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Brucellosis Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 11 million
|
| Forecast Market size by 2029 |
US$ 14 million
|
| Growth Rate |
CAGR of 3.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brucellosis Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brucellosis Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brucellosis Vaccines Overall Market Size
2.1 Global Brucellosis Vaccines Market Size: 2022 VS 2029
2.2 Global Brucellosis Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Brucellosis Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Brucellosis Vaccines Players in Global Market
3.2 Top Global Brucellosis Vaccines Companies Ranked by Revenue
3.3 Global Brucellosis Vaccines Revenue by Companies
3.4 Global Brucellosis Vaccines Sales by Companies
3.5 Global Brucellosis Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Brucellosis Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Brucellosis Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Brucellosis Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Brucellosis Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Brucellosis Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Brucellosis Vaccines Market Size Markets, 2022 & 2029
4.1.2 S19 Vaccine
4.1.3 RB51 Vaccine Strain
4.2 By Type - Global Brucellosis Vaccines Revenue & Forecasts
4.2.1 By Type - Global Brucellosis Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Brucellosis Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Brucellosis Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Brucellosis Vaccines Sales & Forecasts
4.3.1 By Type - Global Brucellosis Vaccines Sales, 2018-2023
4.3.2 By Type - Global Brucellosis Vaccines Sales, 2024-2029
4.3.3 By Type - Global Brucellosis Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Brucellosis Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brucellosis Vaccines Market Size, 2022 & 2029
5.1.2 Cattle
5.1.3 Sheep
5.1.4 Others
5.2 By Application - Global Brucellosis Vaccines Revenue & Forecasts
5.2.1 By Application - Global Brucellosis Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Brucellosis Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Brucellosis Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Brucellosis Vaccines Sales & Forecasts
5.3.1 By Application - Global Brucellosis Vaccines Sales, 2018-2023
5.3.2 By Application - Global Brucellosis Vaccines Sales, 2024-2029
5.3.3 By Application - Global Brucellosis Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Brucellosis Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Brucellosis Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Brucellosis Vaccines Revenue & Forecasts
6.2.1 By Region - Global Brucellosis Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Brucellosis Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Brucellosis Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Brucellosis Vaccines Sales & Forecasts
6.3.1 By Region - Global Brucellosis Vaccines Sales, 2018-2023
6.3.2 By Region - Global Brucellosis Vaccines Sales, 2024-2029
6.3.3 By Region - Global Brucellosis Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Brucellosis Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Brucellosis Vaccines Sales, 2018-2029
6.4.3 US Brucellosis Vaccines Market Size, 2018-2029
6.4.4 Canada Brucellosis Vaccines Market Size, 2018-2029
6.4.5 Mexico Brucellosis Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Brucellosis Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Brucellosis Vaccines Sales, 2018-2029
6.5.3 Germany Brucellosis Vaccines Market Size, 2018-2029
6.5.4 France Brucellosis Vaccines Market Size, 2018-2029
6.5.5 U.K. Brucellosis Vaccines Market Size, 2018-2029
6.5.6 Italy Brucellosis Vaccines Market Size, 2018-2029
6.5.7 Russia Brucellosis Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Brucellosis Vaccines Market Size, 2018-2029
6.5.9 Benelux Brucellosis Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Brucellosis Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Brucellosis Vaccines Sales, 2018-2029
6.6.3 China Brucellosis Vaccines Market Size, 2018-2029
6.6.4 Japan Brucellosis Vaccines Market Size, 2018-2029
6.6.5 South Korea Brucellosis Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Brucellosis Vaccines Market Size, 2018-2029
6.6.7 India Brucellosis Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Brucellosis Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Brucellosis Vaccines Sales, 2018-2029
6.7.3 Brazil Brucellosis Vaccines Market Size, 2018-2029
6.7.4 Argentina Brucellosis Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Brucellosis Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Brucellosis Vaccines Sales, 2018-2029
6.8.3 Turkey Brucellosis Vaccines Market Size, 2018-2029
6.8.4 Israel Brucellosis Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Brucellosis Vaccines Market Size, 2018-2029
6.8.6 UAE Brucellosis Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Jinyu
7.1.1 Jinyu Company Summary
7.1.2 Jinyu Business Overview
7.1.3 Jinyu Brucellosis Vaccines Major Product Offerings
7.1.4 Jinyu Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Jinyu Key News & Latest Developments
7.2 Colorado Serum
7.2.1 Colorado Serum Company Summary
7.2.2 Colorado Serum Business Overview
7.2.3 Colorado Serum Brucellosis Vaccines Major Product Offerings
7.2.4 Colorado Serum Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Colorado Serum Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Brucellosis Vaccines Major Product Offerings
7.3.4 Boehringer Ingelheim Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Biogenesis-Bago
7.4.1 Biogenesis-Bago Company Summary
7.4.2 Biogenesis-Bago Business Overview
7.4.3 Biogenesis-Bago Brucellosis Vaccines Major Product Offerings
7.4.4 Biogenesis-Bago Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Biogenesis-Bago Key News & Latest Developments
7.5 Vetal Company
7.5.1 Vetal Company Company Summary
7.5.2 Vetal Company Business Overview
7.5.3 Vetal Company Brucellosis Vaccines Major Product Offerings
7.5.4 Vetal Company Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Vetal Company Key News & Latest Developments
7.6 CZ Veterinaria
7.6.1 CZ Veterinaria Company Summary
7.6.2 CZ Veterinaria Business Overview
7.6.3 CZ Veterinaria Brucellosis Vaccines Major Product Offerings
7.6.4 CZ Veterinaria Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 CZ Veterinaria Key News & Latest Developments
7.7 SYVA Laboratorios
7.7.1 SYVA Laboratorios Company Summary
7.7.2 SYVA Laboratorios Business Overview
7.7.3 SYVA Laboratorios Brucellosis Vaccines Major Product Offerings
7.7.4 SYVA Laboratorios Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 SYVA Laboratorios Key News & Latest Developments
7.8 Indian Immunologicals
7.8.1 Indian Immunologicals Company Summary
7.8.2 Indian Immunologicals Business Overview
7.8.3 Indian Immunologicals Brucellosis Vaccines Major Product Offerings
7.8.4 Indian Immunologicals Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Indian Immunologicals Key News & Latest Developments
7.9 Qilu
7.9.1 Qilu Company Summary
7.9.2 Qilu Business Overview
7.9.3 Qilu Brucellosis Vaccines Major Product Offerings
7.9.4 Qilu Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Qilu Key News & Latest Developments
7.10 Tecnovax
7.10.1 Tecnovax Company Summary
7.10.2 Tecnovax Business Overview
7.10.3 Tecnovax Brucellosis Vaccines Major Product Offerings
7.10.4 Tecnovax Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Tecnovax Key News & Latest Developments
7.11 Hester Biosciences
7.11.1 Hester Biosciences Company Summary
7.11.2 Hester Biosciences Brucellosis Vaccines Business Overview
7.11.3 Hester Biosciences Brucellosis Vaccines Major Product Offerings
7.11.4 Hester Biosciences Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Hester Biosciences Key News & Latest Developments
7.12 Zoetis
7.12.1 Zoetis Company Summary
7.12.2 Zoetis Brucellosis Vaccines Business Overview
7.12.3 Zoetis Brucellosis Vaccines Major Product Offerings
7.12.4 Zoetis Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Zoetis Key News & Latest Developments
7.13 Onderstepoort Biological
7.13.1 Onderstepoort Biological Company Summary
7.13.2 Onderstepoort Biological Brucellosis Vaccines Business Overview
7.13.3 Onderstepoort Biological Brucellosis Vaccines Major Product Offerings
7.13.4 Onderstepoort Biological Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Onderstepoort Biological Key News & Latest Developments
7.14 Instituto Rosenbusch
7.14.1 Instituto Rosenbusch Company Summary
7.14.2 Instituto Rosenbusch Business Overview
7.14.3 Instituto Rosenbusch Brucellosis Vaccines Major Product Offerings
7.14.4 Instituto Rosenbusch Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Instituto Rosenbusch Key News & Latest Developments
7.15 Ceva Sante Animale
7.15.1 Ceva Sante Animale Company Summary
7.15.2 Ceva Sante Animale Business Overview
7.15.3 Ceva Sante Animale Brucellosis Vaccines Major Product Offerings
7.15.4 Ceva Sante Animale Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 Ceva Sante Animale Key News & Latest Developments
7.16 Calier & Biologicos Laverlam
7.16.1 Calier & Biologicos Laverlam Company Summary
7.16.2 Calier & Biologicos Laverlam Business Overview
7.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Major Product Offerings
7.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Calier & Biologicos Laverlam Key News & Latest Developments
7.17 Biovet
7.17.1 Biovet Company Summary
7.17.2 Biovet Business Overview
7.17.3 Biovet Brucellosis Vaccines Major Product Offerings
7.17.4 Biovet Brucellosis Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 Biovet Key News & Latest Developments
8 Global Brucellosis Vaccines Production Capacity, Analysis
8.1 Global Brucellosis Vaccines Production Capacity, 2018-2029
8.2 Brucellosis Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Brucellosis Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Brucellosis Vaccines Supply Chain Analysis
10.1 Brucellosis Vaccines Industry Value Chain
10.2 Brucellosis Vaccines Upstream Market
10.3 Brucellosis Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Brucellosis Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Brucellosis Vaccines in Global Market
Table 2. Top Brucellosis Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Brucellosis Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Brucellosis Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Brucellosis Vaccines Sales by Companies, (M Doses), 2018-2023
Table 6. Global Brucellosis Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Brucellosis Vaccines Price (2018-2023) & (USD/K Doses)
Table 8. Global Manufacturers Brucellosis Vaccines Product Type
Table 9. List of Global Tier 1 Brucellosis Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brucellosis Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brucellosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Brucellosis Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Brucellosis Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Brucellosis Vaccines Sales (M Doses), 2018-2023
Table 15. By Type - Global Brucellosis Vaccines Sales (M Doses), 2024-2029
Table 16. By Application ? Global Brucellosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Brucellosis Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Brucellosis Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Brucellosis Vaccines Sales (M Doses), 2018-2023
Table 20. By Application - Global Brucellosis Vaccines Sales (M Doses), 2024-2029
Table 21. By Region ? Global Brucellosis Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Brucellosis Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Brucellosis Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Brucellosis Vaccines Sales (M Doses), 2018-2023
Table 25. By Region - Global Brucellosis Vaccines Sales (M Doses), 2024-2029
Table 26. By Country - North America Brucellosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Brucellosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Brucellosis Vaccines Sales, (M Doses), 2018-2023
Table 29. By Country - North America Brucellosis Vaccines Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Brucellosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Brucellosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Brucellosis Vaccines Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Brucellosis Vaccines Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Brucellosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Brucellosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Brucellosis Vaccines Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Brucellosis Vaccines Sales, (M Doses), 2024-2029
Table 38. By Country - South America Brucellosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Brucellosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Brucellosis Vaccines Sales, (M Doses), 2018-2023
Table 41. By Country - South America Brucellosis Vaccines Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Brucellosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Brucellosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Brucellosis Vaccines Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Brucellosis Vaccines Sales, (M Doses), 2024-2029
Table 46. Jinyu Company Summary
Table 47. Jinyu Brucellosis Vaccines Product Offerings
Table 48. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 49. Jinyu Key News & Latest Developments
Table 50. Colorado Serum Company Summary
Table 51. Colorado Serum Brucellosis Vaccines Product Offerings
Table 52. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 53. Colorado Serum Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Brucellosis Vaccines Product Offerings
Table 56. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Biogenesis-Bago Company Summary
Table 59. Biogenesis-Bago Brucellosis Vaccines Product Offerings
Table 60. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 61. Biogenesis-Bago Key News & Latest Developments
Table 62. Vetal Company Company Summary
Table 63. Vetal Company Brucellosis Vaccines Product Offerings
Table 64. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 65. Vetal Company Key News & Latest Developments
Table 66. CZ Veterinaria Company Summary
Table 67. CZ Veterinaria Brucellosis Vaccines Product Offerings
Table 68. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 69. CZ Veterinaria Key News & Latest Developments
Table 70. SYVA Laboratorios Company Summary
Table 71. SYVA Laboratorios Brucellosis Vaccines Product Offerings
Table 72. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 73. SYVA Laboratorios Key News & Latest Developments
Table 74. Indian Immunologicals Company Summary
Table 75. Indian Immunologicals Brucellosis Vaccines Product Offerings
Table 76. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 77. Indian Immunologicals Key News & Latest Developments
Table 78. Qilu Company Summary
Table 79. Qilu Brucellosis Vaccines Product Offerings
Table 80. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 81. Qilu Key News & Latest Developments
Table 82. Tecnovax Company Summary
Table 83. Tecnovax Brucellosis Vaccines Product Offerings
Table 84. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 85. Tecnovax Key News & Latest Developments
Table 86. Hester Biosciences Company Summary
Table 87. Hester Biosciences Brucellosis Vaccines Product Offerings
Table 88. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 89. Hester Biosciences Key News & Latest Developments
Table 90. Zoetis Company Summary
Table 91. Zoetis Brucellosis Vaccines Product Offerings
Table 92. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 93. Zoetis Key News & Latest Developments
Table 94. Onderstepoort Biological Company Summary
Table 95. Onderstepoort Biological Brucellosis Vaccines Product Offerings
Table 96. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 97. Onderstepoort Biological Key News & Latest Developments
Table 98. Instituto Rosenbusch Company Summary
Table 99. Instituto Rosenbusch Brucellosis Vaccines Product Offerings
Table 100. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 101. Instituto Rosenbusch Key News & Latest Developments
Table 102. Ceva Sante Animale Company Summary
Table 103. Ceva Sante Animale Brucellosis Vaccines Product Offerings
Table 104. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 105. Ceva Sante Animale Key News & Latest Developments
Table 106. Calier & Biologicos Laverlam Company Summary
Table 107. Calier & Biologicos Laverlam Brucellosis Vaccines Product Offerings
Table 108. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 109. Calier & Biologicos Laverlam Key News & Latest Developments
Table 110. Biovet Company Summary
Table 111. Biovet Brucellosis Vaccines Product Offerings
Table 112. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 113. Biovet Key News & Latest Developments
Table 114. Brucellosis Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 115. Global Brucellosis Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Brucellosis Vaccines Production by Region, 2018-2023 (M Doses)
Table 117. Global Brucellosis Vaccines Production by Region, 2024-2029 (M Doses)
Table 118. Brucellosis Vaccines Market Opportunities & Trends in Global Market
Table 119. Brucellosis Vaccines Market Drivers in Global Market
Table 120. Brucellosis Vaccines Market Restraints in Global Market
Table 121. Brucellosis Vaccines Raw Materials
Table 122. Brucellosis Vaccines Raw Materials Suppliers in Global Market
Table 123. Typical Brucellosis Vaccines Downstream
Table 124. Brucellosis Vaccines Downstream Clients in Global Market
Table 125. Brucellosis Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Brucellosis Vaccines Segment by Type in 2022
Figure 2. Brucellosis Vaccines Segment by Application in 2022
Figure 3. Global Brucellosis Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brucellosis Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Brucellosis Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Brucellosis Vaccines Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Brucellosis Vaccines Revenue in 2022
Figure 9. By Type - Global Brucellosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Brucellosis Vaccines Price (USD/K Doses), 2018-2029
Figure 13. By Application - Global Brucellosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Brucellosis Vaccines Price (USD/K Doses), 2018-2029
Figure 17. By Region - Global Brucellosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Brucellosis Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 23. US Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 37. China Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Brucellosis Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Brucellosis Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Brucellosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Brucellosis Vaccines Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Brucellosis Vaccines by Region, 2022 VS 2029
Figure 54. Brucellosis Vaccines Industry Value Chain
Figure 55. Marketing Channels
